These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7830855)

  • 1. Hemorheological and hemostatic parameters in children with nephrotic syndrome undergoing steroid therapy.
    André E; Voisin P; André JL; Briquel ME; Stoltz JF; Martinet N; Alexandre P
    Nephron; 1994; 68(2):184-91. PubMed ID: 7830855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic profile in nephrotic syndrome.
    Anand NK; Chand G; Talib VH; Chellani H; Pande J
    Indian Pediatr; 1996 Dec; 33(12):1005-12. PubMed ID: 9141800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma proteinase inhibitor activity and hemostasis tests in children with nephrotic syndrome. Effect of prednisone alone and prednisone plus epsilon-aminocaproic acid treatment regimens: a preliminary report.
    Prandota J; Pankow-Prandota L; Kotecki L; Noga L
    Am J Ther; 2001; 8(2):97-107. PubMed ID: 11304663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of corticosteroids on some hemostatic parameters in children with minimal change nephrotic syndrome.
    Ueda N
    Nephron; 1990; 56(4):374-8. PubMed ID: 2079995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorheological changes in nephrotic syndrome.
    Sahu S; Nageswari K; Banerjee R; Puniyani RR
    Clin Hemorheol Microcirc; 1998 Sep; 19(1):17-20. PubMed ID: 9806728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic problems and thromboembolic complications in nephrotic children.
    Citak A; Emre S; Sâirin A; Bilge I; Nayir A
    Pediatr Nephrol; 2000 Feb; 14(2):138-42. PubMed ID: 10684364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation of the hemostatic system during childhood.
    Andrew M; Vegh P; Johnston M; Bowker J; Ofosu F; Mitchell L
    Blood; 1992 Oct; 80(8):1998-2005. PubMed ID: 1391957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboembolic risk in children with nephrotic syndrome.
    De Mattia D; Penza R; Giordano P; Di Bitonto G; Altomare M; Del Vecchio GC; Schettini F
    Haemostasis; 1991; 21(5):300-4. PubMed ID: 1806458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic measurements in childhood nephrotic syndrome.
    Elidrissy AT; Abdurrahman MB; Bahakim HM; Jones MD; Gader AM
    Eur J Pediatr; 1991 Mar; 150(5):374-8. PubMed ID: 2044614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood viscosity and haemostasis in the nephrotic syndrome.
    McGinley E; Lowe GD; Boulton-Jones M; Forbes CD; Prentice CR
    Thromb Haemost; 1983 Jun; 49(3):155-7. PubMed ID: 6410531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of serum interleukin-7 concentration and the coagulation state in children with nephrotic syndrome.
    Wasilewska A; Zoch-Zwierz WM; Tomaszewska B; Zelazowska B
    Pediatr Int; 2005 Aug; 47(4):424-9. PubMed ID: 16091081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome].
    Wygledowska G; Grygalewicz J; Matuszewska E
    Med Wieku Rozwoj; 2001; 5(4):377-88. PubMed ID: 12004145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
    Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of idiopathic nephrotic syndrome with cyclosporin A].
    Ariceta Iraola G; Rodríguez Soriano J; Vallo Boado A; Quintela Pérez MJ; Oliveros Pérez R
    An Esp Pediatr; 1997 Sep; 47(3):273-8. PubMed ID: 9499280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long versus standard initial steroid therapy for children with the nephrotic syndromeA report from the Southwest Pediatric Nephrology Study Group.
    Lande MB; Gullion C; Hogg RJ; Gauthier B; Shah B; Leonard MB; Bonilla-Felix M; Nash M; Roy S; Strife CF; Arbus G
    Pediatr Nephrol; 2003 Apr; 18(4):342-6. PubMed ID: 12700959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemostatic changes in idiopathic venous thrombosis in childhood and adolescence].
    Nowak-Göttl U; Kreuz WD; Hach-Wunderle V; Freund H; Güngör T; Ehrenforth S; Breddin HK; Kornhuber B
    Klin Padiatr; 1991; 203(6):424-8. PubMed ID: 1758145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Childhood Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome in Saudi Children.
    Alharthi AA
    Clin Pediatr (Phila); 2017 Feb; 56(2):177-183. PubMed ID: 27130200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of tacrolimus with low-dose prednisone in 21 children with steroid-resistant nephrotic syndrome].
    Yao SH; Mao JH; Xia YH; Wang DY; Chen YF; Fang CQ; Liu AM; Du LZ
    Zhonghua Er Ke Za Zhi; 2011 Nov; 49(11):825-8. PubMed ID: 22336304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.